Business registries · firm from USPTO records
SAREPTA THERAPEUTICS, INC.
USPTO only Derived from USPTO records only (patent assignees and trademark owners); FURP found no state registration, Form D, Form ADV, nonprofit, SEC or lobbying record with this name and place.
- Place
- Corvallis, OR
- Entity type
- Not reported
- State of organization
- Not reported
- Patents
- 30 granted 2013-08-06 to 2017-01-03
- Trademarks
- 0
- Record
- EXACT high confidence: USPTO records only: one name
- Source
- USPTO: PVGPATDIS (PVGPATDIS file of 2026-04-10, TRCFECO2 file of 2024-03-27); one name
Patents
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 12653756 | Dose packaging system for medication and method of storing dose therein | 2026-06-16 | PTBLXML, file of 2026-06-16 |
| US 12618850 | Methods for analyzing AAV capsid proteins | 2026-05-05 | PTBLXML, file of 2026-05-05 |
| US 12611436 | AAV transfer cassette | 2026-04-28 | PTBLXML, file of 2026-04-28 |
| US 12590306 | Processes for preparing phosphorodiamidate morpholino oligomers via fast-flow synthesis | 2026-03-31 | PTBLXML, file of 2026-03-31 |
| US 12577540 | Suspension mode seed train development for adherent cells | 2026-03-17 | PTBLXML, file of 2026-03-17 |
| US 12502432 | Bicyclic peptide oligonucleotide conjugates | 2025-12-23 | PVGPATDIS, file of 2026-04-10 |
| US 12391745 | Adeno-associated virus antibodies and fragments thereof | 2025-08-19 | PVGPATDIS, file of 2026-04-10 |
| US 12377150 | Exon skipping oligomer conjugates for muscular dystrophy | 2025-08-05 | PVGPATDIS, file of 2026-04-10 |
| US 12370261 | Chimeric peptides for antisense delivery | 2025-07-29 | PVGPATDIS, file of 2026-04-10 |
| US 12297219 | Phosphorodiamidate morpholino oligomers | 2025-05-13 | PVGPATDIS, file of 2026-04-10 |
| US 12286630 | Treatment methods for muscular dystrophy | 2025-04-29 | PVGPATDIS, file of 2026-04-10 |
| US 12258362 | Processes for preparing phosphorodiamidate morpholino oligomers | 2025-03-25 | PVGPATDIS, file of 2026-04-10 |
| US 12239715 | Peptide oligonucleotide conjugates | 2025-03-04 | PVGPATDIS, file of 2026-04-10 |
| US 12168059 | Trimeric peptides for antisense delivery | 2024-12-17 | PVGPATDIS, file of 2026-04-10 |
| US 12139709 | Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene | 2024-11-12 | PVGPATDIS, file of 2026-04-10 |
| US 12138312 | Cell-penetrating peptides for antisense delivery | 2024-11-12 | PVGPATDIS, file of 2026-04-10 |
| US 12121532 | Modified antisense oligomers for exon inclusion in spinal muscular atrophy | 2024-10-22 | PVGPATDIS, file of 2026-04-10 |
| US 12104163 | Adeno-associated virus vectors for treatment of Rett syndrome | 2024-10-01 | PVGPATDIS, file of 2026-04-10 |
| US 11932851 | Exon skipping compositions for treating muscular dystrophy | 2024-03-19 | PVGPATDIS, file of 2026-04-10 |
| US 11925675 | Systemic delivery of adeno-associated virus vector expressing gamma-sarcoglycan and the treatment of muscular dystrophy | 2024-03-12 | PVGPATDIS, file of 2026-04-10 |
| US 11911403 | Antisense-induced exon exclusion in type VII collagen | 2024-02-27 | PVGPATDIS, file of 2026-04-10 |
| US 11802283 | Oligonucleotide analogues targeting human LMNA | 2023-10-31 | PVGPATDIS, file of 2026-04-10 |
| US 11732259 | Peptide oligonucleotide conjugates | 2023-08-22 | PVGPATDIS, file of 2026-04-10 |
| US 11674139 | Oligonucleotides for treating expanded repeat diseases | 2023-06-13 | PVGPATDIS, file of 2026-04-10 |
| US 11672871 | Peptide oligonucleotide conjugates | 2023-06-13 | PVGPATDIS, file of 2026-04-10 |
The newest 25 of 30. All patents of this assignee
Trademarks
No US trademarks on file under this name.
Possible related entities
No other firm on file at the same street address (no street address in these USPTO records).
Firms here are built from USPTO patent assignees (PatentsView) and trademark owners: one firm per name (legal endings aside) and state, or country outside the US. Matches to other records are by name and state: EXACT means the identical full name, FUZZY a looser match, with the confidence shown.